...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Exempt Distribution Jan 20
4
Jan 26, 2021 06:54PM
3
Jan 30, 2021 09:09AM

AM I nuts this is the same stock at 1/3 price! Worth picking up a couple of k

5
Jan 30, 2021 12:30PM
Share
New Message
Please login to post a reply